<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="case-report">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">An Bras Dermatol</journal-id>
      <journal-id journal-id-type="iso-abbrev">An Bras Dermatol</journal-id>
      <journal-id journal-id-type="publisher-id">An Bras Dermatol</journal-id>
      <journal-title-group>
        <journal-title>Anais Brasileiros de Dermatologia</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0365-0596</issn>
      <issn pub-type="epub">1806-4841</issn>
      <publisher>
        <publisher-name>Sociedade Brasileira de Dermatologia</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">24346870</article-id>
      <article-id pub-id-type="pmc">3875983</article-id>
      <article-id pub-id-type="doi">10.1590/abd1806-4841.20132476</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Case Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Extra ocular sebaceous adenocarcinoma in HIV-positive patient - case
report<xref ref-type="fn" rid="fn01">*</xref>
</article-title>
        <trans-title-group xml:lang="pt">
          <trans-title>Adenocarcinoma seb&#xE1;ceo extra-ocular em paciente HIV positivo - relato de
caso</trans-title>
        </trans-title-group>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Menezes</surname>
            <given-names>Carla Kellen da Silva</given-names>
          </name>
          <xref ref-type="aff" rid="aff01">1</xref>
          <xref ref-type="corresp" rid="c01"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Gomes</surname>
            <given-names>Nath&#xE1;lia Matos</given-names>
          </name>
          <xref ref-type="aff" rid="aff02">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Jalkh</surname>
            <given-names>Alex Panizza</given-names>
          </name>
          <xref ref-type="aff" rid="aff03">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Franco</surname>
            <given-names>Emily dos Santos</given-names>
          </name>
          <xref ref-type="aff" rid="aff04">4</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Martins</surname>
            <given-names>Thalita Gomes</given-names>
          </name>
          <xref ref-type="aff" rid="aff05">5</xref>
        </contrib>
      </contrib-group>
      <aff id="aff01"><label>1</label> MD, resident on the Surgical Pathology program at Amazonas Federal
University (UFAM) - Manaus (AM), Brazil.</aff>
      <aff id="aff02"><label>2</label> MD, resident on the Dermatology program at Dr. Heitor Vieira Dourado
Amazonas Tropical Medicine Foundation (FMTAM) - Manaus (AM), Brazil.</aff>
      <aff id="aff03"><label>3</label> MD, Dermatologist, MSc in Infectious and Tropical Diseases, preceptor
of the dermatology residents at Dr. Heitor Vieira Dourado Amazonas Tropical Medicine
Foundation (FMTAM) - Manaus (AM), Brazil.</aff>
      <aff id="aff04"><label>4</label> MD, resident on the Surgical Pathology program at Amazonas Federal
University (UFAM) - Manaus (AM), Brazil.</aff>
      <aff id="aff05"><label>5</label> MD, resident on the Surgical Pathology program at Amazonas Federal
University (UFAM) - Manaus (AM), Brazil.</aff>
      <author-notes>
        <corresp id="c01"><bold>Mailing address:</bold> Carla Kellen da Silva Menezes, Av. Pedro Teixeira, 25 -
Dom Pedro I, 69.040-000 - Manaus - AM, Brazil. E-mail:
<email>carlakmenezes@yahoo.com.br</email></corresp>
      </author-notes>
      <pub-date pub-type="ppub">
        <season>Nov-Dec</season>
        <year>2013</year>
      </pub-date>
      <volume>88</volume>
      <issue>6 Suppl 1</issue>
      <fpage>19</fpage>
      <lpage>22</lpage>
      <history>
        <date date-type="received">
          <day>22</day>
          <month>1</month>
          <year>2013</year>
        </date>
        <date date-type="accepted">
          <day>20</day>
          <month>5</month>
          <year>2013</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9;2013 by Anais Brasileiros de Dermatologia</copyright-statement>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/">
          <license-p>This is an Open Access article distributed under the terms of the Creative
Commons Attribution Non-Commercial License, which permits unrestricted
non-commercial use, distribution, and reproduction in any medium, provided the
original work is properly cited.</license-p>
        </license>
      </permissions>
      <abstract>
        <p>Sebaceous adenocarcinoma is a rare adnexal tumor that can affect the skin and is
divided into ocular, a more common form and extra ocular, of a rarer occurrence. We
report the case of a patient diagnosed with Acquired Immune Deficiency Syndrome
(AIDS) who developed an extra ocular, bulky and fast-growing sebaceous adenocarcinoma
on the face. The literature has suggested that transplanted patients and HIV-positive
patients have an excess risk for developing adnexal tumors, including sebaceous
adenocarcinoma.</p>
      </abstract>
      <trans-abstract xml:lang="pt">
        <p>Adenocarcinoma seb&#xE1;ceo &#xE9; um tumor anexial raro que pode envolver a pele e &#xE9; dividido
em ocular, mais comum e extraocular, mais raro. Relatamos o caso de um paciente com
diagn&#xF3;stico de S&#xED;ndrome da Imunodefici&#xEA;ncia Adquirida que desenvolveu um
adenocarcinoma seb&#xE1;ceo extra-ocular, na face, volumoso, de r&#xE1;pido crescimento. A
literatura tem sugerido que pacientes transplantados e portadores do v&#xED;rus da
imunodefici&#xEA;ncia humana t&#xEA;m um excesso de risco para o desenvolvimento de tumores
anexiais, incluindo o Adenocarcinoma seb&#xE1;ceo.</p>
      </trans-abstract>
      <kwd-group>
        <kwd>Adenocarcinoma, sebaceous</kwd>
        <kwd>HIV</kwd>
        <kwd>Immunosuppression</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec>
      <title>INTRODUCTION</title>
      <p>Sebaceous adenocarcinoma (ACS) is a rare adnexal tumor that may affect the skin, and
that is usually classified into two categories: ocular and extra ocular.<sup><xref ref-type="bibr" rid="r01">1</xref>-<xref ref-type="bibr" rid="r03">3</xref></sup>
</p>
      <p>It frequently appears on the ocular region, particularly on the eyelids, in 75% of the
cases; however it can occur in other body parts, as well.<sup><xref ref-type="bibr" rid="r01">1</xref>,<xref ref-type="bibr" rid="r02">2</xref>,<xref ref-type="bibr" rid="r04">4</xref></sup>
</p>
      <p>Extra ocular tumors correspond roughly to a quarter of all cases and are mostly located
on the head and neck areas, which have larger quantities of sebaceous glands.<sup><xref ref-type="bibr" rid="r01">1</xref>-<xref ref-type="bibr" rid="r03">3</xref></sup>
</p>
      <p>The incidence of extra ocular ACS is higher in men, with a rate as high as 2:1,
occurring commonly during the seventh decade of life.<sup><xref ref-type="bibr" rid="r01">1</xref>,<xref ref-type="bibr" rid="r03">3</xref>,<xref ref-type="bibr" rid="r05">5</xref></sup>
</p>
      <p>Clinically these tumors appear, in general, as a nodular or cystic nodular mass,
measuring up to 8 centimeters, with poorly defined margins, and tending to
ulcerate.<sup><xref ref-type="bibr" rid="r01">1</xref>,<xref ref-type="bibr" rid="r02">2</xref>,<xref ref-type="bibr" rid="r03">3</xref>,<xref ref-type="bibr" rid="r04">4</xref>,<xref ref-type="bibr" rid="r06">6</xref></sup>
</p>
      <p>It is suggested that, patients submitted to transplants or those diagnosed with
HIV-positive have an excess of risk of developing adnexal tumors, including ACS, however
the reasons for this is not yet clearly elucidated.<sup><xref ref-type="bibr" rid="r07">7</xref></sup>
</p>
      <p>The goal of this report is to present the case of a patient, previously diagnosed with
AIDS, who developed a facial extra ocular ACS and also to discuss the literature data
regarding the mechanisms involved in the development of such neoplasms in HIV-positive
patients.</p>
    </sec>
    <sec>
      <title>CASE REPORT</title>
      <p>A forty-two year old male patient, diagnosed with AIDS on the previous year, sought
medical attention after presenting with daily fever, watery diarrhea, generalized
myalgia and weight loss for a week. </p>
      <p>Besides these symptoms, the patient reported an asymptomatic facial mass, growing in the
last four weeks. </p>
      <p>On physical examination the patient had a poor general status, was emaciated and
febrile. On the right mandibular region an exophytic tumor (3 x 1.5 cm) was noticeable,
presenting with an infiltrated base and exulcerated areas (<xref ref-type="fig" rid="f01">Figure 1</xref>). The exam also detected generalized lymphadenomegaly. </p>
      <fig id="f01" orientation="portrait" position="float">
        <label>FIGURE 1</label>
        <caption>
          <p>Extra ocular sebaceous adenocarcinoma: exophytic, voluminous, irregular tumoral
lesion, with an infiltrated base and exulcerated areas presenting with hematic
crusts on the surface. The lesion is located on the right mandibular area of an
HIV-positive patient.</p>
        </caption>
        <graphic xlink:href="abd-88-06-s1-0019-g01"/>
      </fig>
      <p>Laboratory exams showed: HIV viral load: 55,986; CD4 count: 96; anemia (hemoglobin:
9.2mg/dl) and lactic dehydrogenase (LDH): 1,965mg/dl. </p>
      <p>Tissue obtained from the excisional biopsy was stained with hematoxiline eosine (HE) and
revealed an ulcerated neoplasm, formed by stacks of basaloid cells with eosinophilic
cytoplasm, centered by a population of cells with micro vacuolated cytoplasm and
irregular, hyperchromic nuclei with mitotic Figures and necrotic areas, characteristics
consistent with ACS (<xref ref-type="fig" rid="f02">Figures 2</xref> and <xref ref-type="fig" rid="f03">3</xref>). </p>
      <fig id="f02" orientation="portrait" position="float">
        <label>FIGURE 2</label>
        <caption>
          <p>Sebaceous adenocarcinoma: poorly delimitated lobules formed by stacks of basaloid
cells with eosinophilic cytoplasm, centered by a population of cells with micro
vacuolated cytoplasm, and hyperchromic, irregular nuclei. (HE 20X)</p>
        </caption>
        <graphic xlink:href="abd-88-06-s1-0019-g02"/>
      </fig>
      <fig id="f03" orientation="portrait" position="float">
        <label>FIGURE 3</label>
        <caption>
          <p>Sebaceous adenocarcinoma: presence of mitotic figures (HE 40x)</p>
        </caption>
        <graphic xlink:href="abd-88-06-s1-0019-g03"/>
      </fig>
      <p>To confirm the diagnosis, we performed an immunohistochemistry study (IMQ) that revealed
expression of cytokeratin and protein p63 on the basaloid cells and EMA on the micro
vacuolated cells, findings that were consonant with ACS (<xref ref-type="fig" rid="f04">Figure 4</xref>). </p>
      <fig id="f04" orientation="portrait" position="float">
        <label>FIGURE 4</label>
        <caption>
          <p>Sebaceous adenocarcinoma: immunohistochemistry study showing positivity for
epithelial membrane antigen (EMA) on micro vacuolated cells</p>
        </caption>
        <graphic xlink:href="abd-88-06-s1-0019-g04"/>
      </fig>
      <p>During admission, a computerized tomography of the chest showed signs suggestive of
either bronchiolitis or endobronchial dissemination of pulmonary tuberculosis.
Therefore, treatment with antiretroviral therapy, antibiotics and COXCIP 4 (rifampicin,
isoniazid, pyrazinamide and ethambutol) were initiated, however, there was a progressive
deterioration on the clinical status and the patient died due to respiratory failure,
after seventy days of hospitalization. </p>
    </sec>
    <sec sec-type="discussion">
      <title>DISCUSSION</title>
      <p>We report a case of a voluminous, fast-growing, facial ACS, in an HIV-positive patient.
This tumor is characterized histologically by the proliferation of poorly delimitated
dermic lobules, formed by basaloid cells and other more mature cells with an slightly
vacuolized cytoplasm, separated by fibrovascular stroma without obvious desmoplasia. The
central portions of these cellular nests may become necrotic, giving a comedo-like
appearance.<sup><xref ref-type="bibr" rid="r01">1</xref>,<xref ref-type="bibr" rid="r02">2</xref></sup>
</p>
      <p>Special stains for lipids, such as black Sudan, may be used when there is fresh tissue
available and they are often positive in ACS and negative in other tumor such as
clear-cell carcinoma, squamous-cell carcinoma (CEC) and hidradenocarcinoma, among
others.<sup><xref ref-type="bibr" rid="r01">1</xref></sup>
</p>
      <p>Immunohistochemistry is usually unnecessary to diagnose ACS. Diagnosis may be obtained
with HE, however, neoplastic cells are usually positive for epithelial membrane antigen
(EMA), proteins p63 and p53, cytokeratin, the product of oncogene c-erb-2, glycoprotein
EP4 BER and adipophilin, a more recent marker.<sup><xref ref-type="bibr" rid="r01">1</xref>,<xref ref-type="bibr" rid="r03">3</xref></sup>
</p>
      <p>Differential diagnosis for ACS are ample and include practically all skin clear-cell
malignant tumors, such as balloon-cell melanoma (MCB), CEC, clear-cell basocellular
carcinoma (CBC), and clear-cell eccrine carcinoma, among others. None of these
neoplasms, however, except for MCB, presents the same multivesicular, bubble-like,
cytoplasmic vacuolization pattern seen in sebocytes. MCB is positive for protein S-100,
HMB-45 or melanoma antigen recognized by T1-cells (MART-1).<sup><xref ref-type="bibr" rid="r01">1</xref>,<xref ref-type="bibr" rid="r02">2</xref></sup>
</p>
      <p>Basaloid ACS is also discernible from CBC with sebaceous differentiation, because its
nuclei are more vesiculated than those of CBC. Besides, basaloid ACS's stroma is not
fibromixoid and the number of sebocytes is small. In contrast, CBC with sebaceous
differentiation presents with clusters of mature sebaceous elements. Both basaloid ACS
and CBC with sebaceous differentiation express glycoprotein-EP4 BER on
immunohistochemistry, but the differ in their expression of EMA. ACS is diffusely
EMA-reactive, whilst the other one is either EMA-negative or only focally
positive.<sup><xref ref-type="bibr" rid="r02">2</xref></sup>
</p>
      <p>This report presented the case of an HIV-positive patient with ACS. Medical literature
suggests these patients have a higher risk of developing adnexal neoplasms (NA),
including ACS, the causes for this, however are not yet elucidated. </p>
      <p>It is known that chronic exposure to solar ultraviolet radiation is the main risk factor
for developing several types of skin cancer and also that the evolution of these tumors
in HIV-positive patients is related to the duration of the disease.<sup><xref ref-type="bibr" rid="r07">7</xref>,<xref ref-type="bibr" rid="r08">8</xref></sup>
</p>
      <p>A recent study demonstrated the higher incidence rates of Merkel cell carcinomas and NA,
especially ACS, in patients with AIDS when compared to the population in general,
suggesting that immunosuppression is an important risk factor for this
neoplasms.<sup><xref ref-type="bibr" rid="r07">7</xref>,<xref ref-type="bibr" rid="r08">8</xref>,<xref ref-type="bibr" rid="r09">9</xref></sup>
</p>
      <p>In Japan, human papilloma virus (HPV) was linked to some cases of ACS. However, the same
result was not found in the United States, where seven patients evaluated in a study
were negative for HPV.<sup><xref ref-type="bibr" rid="r10">10</xref></sup>
</p>
      <p>These observations advocate that those tumors occur, at least in part, due to the loss
of control of the immune system to an oncogenic virus, even though as a result of the
rarity of these lesions, data are limited.<sup><xref ref-type="bibr" rid="r07">7</xref>,<xref ref-type="bibr" rid="r08">8</xref></sup>Nonetheless, one cannot
deny the relevance of HIV-induced immunosuppression in the etiology of these neoplasms. </p>
      <p>NA in HIV-positive patients are scarcely represented in the world medical literature,
therefore, we not only reported this case of an unusual tumor, but we propose that more
cases might be documented and more studies performed on this topic, first and foremost
to ensure a decrease in morbimortality and also a better understanding of the mechanisms
involved.</p>
    </sec>
  </body>
  <back>
    <fn-group>
      <fn id="fn01" fn-type="other">
        <p>* Work performed at Dr. Heitor Vieira Dourado Amazonas Tropical Medicine Foundation
(FMTAM) - Manaus (AM), Brazil.</p>
      </fn>
      <fn id="fn02" fn-type="financial-disclosure">
        <p>Financial Support: None</p>
      </fn>
      <fn id="fn03" fn-type="conflict">
        <p>None Conflict of Interest: None.</p>
      </fn>
    </fn-group>
    <ref-list>
      <title>REFERENCES </title>
      <ref id="r01">
        <label>1</label>
        <element-citation publication-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Calonje</surname>
              <given-names>EJ</given-names>
            </name>
            <name>
              <surname>Brenn</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Lazar</surname>
              <given-names>AJ</given-names>
            </name>
            <name>
              <surname>McKee</surname>
              <given-names>PH</given-names>
            </name>
          </person-group>
          <source>McKee's Pathology of the Skin With Clinical Correlations</source>
          <publisher-loc>Edinburgh</publisher-loc>
          <publisher-name>Elsevier/Saunders</publisher-name>
          <year>2012</year>
          <fpage>501</fpage>
          <lpage>505</lpage>
        </element-citation>
      </ref>
      <ref id="r02">
        <label>2</label>
        <element-citation publication-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Crowson</surname>
              <given-names>AN</given-names>
            </name>
            <name>
              <surname>Magro</surname>
              <given-names>CM</given-names>
            </name>
            <name>
              <surname>Piepkorn</surname>
              <given-names>MW</given-names>
            </name>
          </person-group>
          <chapter-title>Dermatophatology</chapter-title>
          <person-group person-group-type="editor">
            <name>
              <surname>Barnhill</surname>
              <given-names>RL</given-names>
            </name>
          </person-group>
          <source>Dermatopathology</source>
          <publisher-loc>New York</publisher-loc>
          <publisher-name>The McGraw-Hill Companies</publisher-name>
          <year>2010</year>
          <fpage>693</fpage>
          <lpage>695</lpage>
        </element-citation>
      </ref>
      <ref id="r03">
        <label>3</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>D&#xED;ez</surname>
              <given-names>JRF</given-names>
            </name>
          </person-group>
          <article-title xml:lang="es">Neoplasias malignas de anexos cut&#xE1;neos. Experiencia con
247 casos (Cutaneous adnexal malignant neoplasms. Experience of 247 cases -
original in Spanish)</article-title>
          <source>Rev Latinoam Patol</source>
          <year>2011</year>
          <volume>1</volume>
          <fpage>19</fpage>
        </element-citation>
      </ref>
      <ref id="r04">
        <label>4</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Eisen</surname>
              <given-names>DB</given-names>
            </name>
            <name>
              <surname>Michael</surname>
              <given-names>JD</given-names>
            </name>
          </person-group>
          <article-title>Sebaceous lesions and their associated syndromes: Part
I</article-title>
          <source>J Am Acad Dermatol</source>
          <year>2009</year>
          <volume>61</volume>
          <fpage>549</fpage>
          <lpage>560</lpage>
          <pub-id pub-id-type="pmid">19751879</pub-id>
        </element-citation>
      </ref>
      <ref id="r05">
        <label>5</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Dores</surname>
              <given-names>GM</given-names>
            </name>
            <name>
              <surname>Curtis</surname>
              <given-names>RE</given-names>
            </name>
            <name>
              <surname>Toro</surname>
              <given-names>JR</given-names>
            </name>
            <name>
              <surname>Devesa</surname>
              <given-names>SS</given-names>
            </name>
            <name>
              <surname>Fraumeni</surname>
              <given-names>JF</given-names>
              <suffix>Jr</suffix>
            </name>
          </person-group>
          <article-title>Incidence of cutaneous sebaceous carcinoma and risk of associated
neoplasms: Insight into Muir-Torr&#xE9; syndrome</article-title>
          <source>Cancer</source>
          <year>2008</year>
          <volume>113</volume>
          <fpage>3372</fpage>
          <lpage>3381</lpage>
          <pub-id pub-id-type="pmid">18932259</pub-id>
        </element-citation>
      </ref>
      <ref id="r06">
        <label>6</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Schlauder</surname>
              <given-names>SM</given-names>
            </name>
            <name>
              <surname>Morgan</surname>
              <given-names>MB</given-names>
            </name>
          </person-group>
          <article-title>Cutaneous Neoplasms with Sebaceous Differentiation: A
Review</article-title>
          <source>Pathol Case Rev</source>
          <year>2007</year>
          <volume>2</volume>
          <fpage>79</fpage>
          <lpage>85</lpage>
        </element-citation>
      </ref>
      <ref id="r07">
        <label>7</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lanoy</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Dores</surname>
              <given-names>GM</given-names>
            </name>
            <name>
              <surname>Madeleine</surname>
              <given-names>MM</given-names>
            </name>
            <name>
              <surname>Toro</surname>
              <given-names>JR</given-names>
            </name>
            <name>
              <surname>Fraumeni</surname>
              <given-names>JF</given-names>
              <suffix>Jr</suffix>
            </name>
            <name>
              <surname>Engels</surname>
              <given-names>EA</given-names>
            </name>
          </person-group>
          <article-title> Epidemiology of non-keratinocytic skin cancers among persons with
acquired immunodeficiency syndrome in the U.S </article-title>
          <source>AIDS</source>
          <year>2009</year>
          <volume>23</volume>
          <fpage>385</fpage>
          <lpage>393</lpage>
          <pub-id pub-id-type="pmid">19114864</pub-id>
        </element-citation>
      </ref>
      <ref id="r08">
        <label>8</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Engels</surname>
              <given-names>AE</given-names>
            </name>
          </person-group>
          <article-title>Non-AIDS-defining malignancies in HIV-infected persons: etiologic
puzzles, epidemiologic perils, and prevention opportunities</article-title>
          <source>AIDS</source>
          <year>2009</year>
          <volume>23</volume>
          <fpage>875</fpage>
          <lpage>885</lpage>
          <pub-id pub-id-type="pmid">19349851</pub-id>
        </element-citation>
      </ref>
      <ref id="r09">
        <label>9</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lanoy</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Costagliola</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Engels</surname>
              <given-names>EA</given-names>
            </name>
          </person-group>
          <article-title>Skin cancers associated with HIV infection and solid organ transplant
among elderly adults</article-title>
          <source>Int J Cancer</source>
          <year>2010</year>
          <volume>126</volume>
          <fpage>1724</fpage>
          <lpage>1731</lpage>
          <pub-id pub-id-type="pmid">19810102</pub-id>
        </element-citation>
      </ref>
      <ref id="r10">
        <label>10</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yen</surname>
              <given-names>MT</given-names>
            </name>
            <name>
              <surname>Tse</surname>
              <given-names>DT</given-names>
            </name>
          </person-group>
          <article-title>Sebaceous Cell Carcinoma of the Eyelid and the Human Immunodeficiency
Virus</article-title>
          <source>Ophthal Plast Reconstr Surg</source>
          <year>2000</year>
          <volume>16</volume>
          <fpage>206</fpage>
          <lpage>210</lpage>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
